Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 44Liver Neoplasms 18Colorectal Neoplasms 15Neoplasm Metastasis 11Cholangiocarcinoma 11Pancreatic Neoplasms 9Colonic Neoplasms 9Barrett Esophagus 7Rectal Neoplasms 6Recurrence 5Esophageal Neoplasms 4Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Hepatitis B 2Gallbladder Neoplasms 2Stomach Neoplasms 1Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Pancreatic cancer, adult 1Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Neoplasm Micrometastasis 1Multi-organ Metastatic Colorectal Cancer 1Liver Metastasis Colon Cancer 1Klatskin Tumor 1Jaundice, Obstructive 1Hypertension, Portal 1Hepatitis B, Chronic 1

Interventions

Fluorouracil 67Radiotherapy 53Cisplatin 52Oxaliplatin 47Leucovorin 37Paclitaxel 36Irinotecan 27Docetaxel 23Capecitabine 20Nivolumab 17Carboplatin 16pembrolizumab 15Radiation 15Neoadjuvant Therapy 15Surgical Procedures, Operative 12Cetuximab 12durvalumab 9Drug Therapy 9Biopsy 9Taxes 8Folfox protocol 8Chemotherapy, Adjuvant 8Trastuzumab 7Magnetic Resonance Spectroscopy 7Gefitinib 7Endoscopy 7tremelimumab 6Specimen Handling 6Endoscopy, Digestive System 6Ramucirumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma Of Esophagus × Radiofrequency Ablation × Gastrointestinal × Clear all
NCT06732388 2026-05-13

Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus

National Cancer Institute (NCI)

Phase 2 Not yet recruiting
64 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Barrett Esophagus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡